A-shares open · 港股交易中 Quotes 行情 · 28 Sep 10:09 CST
28 Sep 2026 · 10:09 CST Terminal Access 终端入口 →

Cheng Zengjiang 程增江

Male 男 · 60 years old · Doctorate 博士 · Three seats at three companies · Identity confirmed by person code

Companies 任职公司

Company 公司Industry 行业Role 职务Since 起始Grade 评级
Brightgene 博瑞医药Chemical Pharmaceuticals 化学制药Independent Director 独立董事27 Sep 2024D 45
Zelgen 泽璟制药Chemical Pharmaceuticals 化学制药Independent Director 独立董事16 May 2025B 77
Easton Bio Pharmaceuticals 苑东生物Chemical Pharmaceuticals 化学制药Independent Director 独立董事27 Dec 2024C 63

Biography 简历

程增江,1966年6月出生,中国国籍,无境外永久居留权,博士研究生学历。曾任山东省济南军区药检所主管药师,北京市解放军301医院助理研究员,北京正力健医药科技公司/北京悦康集团思普润安医药科技有限公司技术总监/总经理,四环医药控股集团研发总监等职。现任同写意(北京)科技发展有限公司董事长,科贝源(北京)生物医药科技有限公司董事长。兼任中国食品药品企业质量安全促进会副会长,中国医药企业管理协会新药研发与注册专委会执行主任。苏州工业园区第十四届第一批科技领军人才。苏州百拓生物创业导师,Merck中国创新中心导师。招商银行特聘专家,深圳市坪山区顾问,苏州吴中生物医药产业园特别顾问,中国医药城科研发展顾问,成都医学城顾问,成都高新区招商大使。现任公司独立董事、成都苑东生物制药股份有限公司独立董事、苏州泽璟生物制药股份有限公司独立董事。

English Translation 英文译文 · Organisation Names in Chinese 机构名称保留中文Cheng Zengjiang, born in June 1966, Chinese nationality, no overseas permanent residence, doctoral degree. Has served as Chief Pharmacist of Shandong Provincial Jinan Military Region Drug Testing Institute, Assistant Researcher of Beijing PLA 301 Hospital, Technical Director/General Manager of 北京正力健医药科技公司/北京悦康集团思普润安医药科技有限公司, R&D Director of 四环医药控股集团, among other positions. Currently serves as Chairman of 同写意(北京)科技发展有限公司, Chairman of 科贝源(北京)生物医药科技有限公司. Also serves as Vice Chairman of 中国食品药品企业质量安全促进会, Executive Director of 中国医药企业管理协会 New Drug R&D and Registration Special Committee. Suzhou Industrial Park 14th First Batch of Science and Technology Leaders. Suzhou Bai Tuo Biotechnology Startup Mentor, Merck China Innovation Center Mentor. Specially Appointed Expert of 招商银行, Advisor of Pingshan District, Shenzhen, Special Advisor of Suzhou Wuzhong Biomedical and Pharmaceutical Industrial Park, 中国医药 (China Meheco) City R&D Development Advisor, Advisor of Chengdu Medical City, Chengdu High-tech Zone Investment Promotion Ambassador. Currently serves as Independent Director of the company, Independent Director of 成都苑东生物制药股份有限公司 (Easton Bio Pharmaceuticals), Independent Director of 苏州泽璟生物制药股份有限公司 (Zelgen).